Recent findings published in the Journal of Clinical Investigation have identified a protein, Ephexin5, that could be targeted to prevent and treat the systems of Alzheimer’s disease (AD). Studies in mice demonstrated that blocking the protein’s expression led to a reduction in cognitive impairment in mouse AD models, therefore making it a promising therapeutic target for the treatment of AD.
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.